Stimulating Blood Vessel Growth in Brain with FGF1 May Hold Promise as PD Treatment, Company Says

Stimulating Blood Vessel Growth in Brain with FGF1 May Hold Promise as PD Treatment, Company Says
Stimulating the growth of blood vessels in the brain through the use of fibroblast growth factor 1 (FGF1) may hold promise as a strategy for treating Parkinson’s disease, according to a white paper released by Zhittya Genesis Medicine (ZGM). Clinical trials testing this theory are being planned. The white paper is titled “Parkinson’s Disease: Therapeutic Angiogenesis as a Disease Modifying, ... read more
Source: Parkinson’s News TodayPublished on 2020-01-22By Marisa Wexler